Local immunotherapy in allergy: prospects for the future

Area of Science:

• Allergy and Immunology
• Immunotherapy Research

Background:

• Sublingual immunotherapy (SLIT) is a developing allergy treatment with a long history but recent clinical application.
• Growing evidence supports SLIT efficacy, yet significant questions persist regarding its immunological basis, administration, and safety.
• Limited comparative studies exist between SLIT and subcutaneous immunotherapy (SCIT), hindering definitive treatment recommendations.

Purpose of the Study:

• To review the current state of sublingual immunotherapy for allergic diseases.
• To identify knowledge gaps in immunological mechanisms, application modes, and long-term outcomes of SLIT.
• To discuss factors influencing clinician and patient acceptance of different immunotherapy approaches.

Main Methods:

• Literature review of controlled studies on sublingual immunotherapy.
• Analysis of comparative studies between SLIT and subcutaneous immunotherapy.
• Examination of factors affecting patient compliance and acceptance.

Main Results:

• Controlled studies increasingly demonstrate the effectiveness of SLIT.
• Key questions regarding immunological mechanisms, optimal application, and long-term side effects remain unresolved.
• Comparative data between SLIT and SCIT are insufficient for definitive recommendations.
• Patient compliance and acceptance are crucial but often unaddressed factors.

Conclusions:

• Sublingual immunotherapy is a promising, though not fully understood, treatment for allergies.
• Further research is essential to clarify mechanisms, optimize application, and establish long-term safety profiles.
• Addressing patient and physician perspectives is vital for wider SLIT adoption.